The Italian group announces today the appointment of Nicholas Reed as Vice President of Innovation and Audiology Research worldwide. This position was tailor-made for the researcher, recognized internationally for his work on the links between hearing loss and overall health.
Nicholas Reed, who holds a Doctorate in Audiology from Towson University and Public Health with a specialization in Epidemiology from Johns Hopkins University, has been working for years on the connections between hearing loss and healthy aging, both clinically and population-based. Prior to joining Amplifon, he was an associate professor at New York University School of Medicine in the ENT department. Among his recent publications, several explore the gaps in audiology research regarding the connections between hearing loss, cognitive abilities, comorbidities. He is a co-author of the Achieve trial analysis, which identified the effects of hearing aids in slowing cognitive decline.
Based in Minneapolis, the American headquarters of the Amplifon group, Nicholas Reed will be tasked with strengthening partnerships with research and ensuring that the company remains positioned at the intersection of clinical excellence and cutting-edge technologies. “His appointment represents a major investment by Amplifon in the future of hearing care,” said CEO Enrico Vita. “By integrating Dr. Reed’s expertise in epidemiology and clinical audiology, we will enhance our protocols and make our services even more innovative, personalized, and effective, with the aim of improving the quality of life for millions of people worldwide.”
“I am delighted to support Amplifon’s efforts in healthcare innovation by strengthening ties with the scientific community to ensure everyone has access to the highest quality hearing care based on evidence-based practices,” said Nicholas Reed.
